Clinical Trial Update: Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating long-term safety and efficacy of DWP16001 add-on to metformin in patients with type 2 diabetes inadequately controlled on metfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DWP16001
• metformin (metformin)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: COMPLETED